Sponsored Links
| CDC's Advisory Committee On Immunization Practices Recommends Pfizer's Prevnar 13™ Vaccine For The Prevention Of Invasive Pneumococcal Disease |
 |
 |
 |
| Pharmacy - Pharma Industry - Biotech Industry | |||
|
Pfizer Inc (NYSE:PFE) announced that the United States Centers for Disease Control and Prevention's (CDC's) Advisory Committee on Immunization Practices (ACIP) has recommended the use of Prevnar 13™ (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) for healthy children aged 2 months through 59 months for the prevention of invasive pneumococcal disease... Read more: Pharma Industry / Biotech Industry News From Medical News Today
|